UMB Bank’s VanEck Biotech ETF BBH Stock Holding History

UMB Bank’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$169K	Hold	900	–	–	﹤0.01%	741
2025 Q4	$170K	Hold	900	–	–	﹤0.01%	723
2025 Q3	$149K	Hold	900	–	–	﹤0.01%	713
2025 Q2	$138K	Hold	900	–	–	﹤0.01%	712
2025 Q1	$142K	Sell	900 -52	-5%	-$8.44K	﹤0.01%	659
2024 Q4	$149K	Buy	952 +52	+6%	+$8.75K	﹤0.01%	619
2024 Q3	$160K	Hold	900	–	–	﹤0.01%	618
2024 Q2	$152K	Hold	900	–	–	﹤0.01%	610
2024 Q1	$150K	Hold	900	–	–	﹤0.01%	624
2023 Q4	$149K	Hold	900	–	–	﹤0.01%	639
2023 Q3	$140K	Hold	900	–	–	﹤0.01%	634
2023 Q2	$140K	Hold	900	–	–	﹤0.01%	642
2023 Q1	$146K	Hold	900	–	–	﹤0.01%	624
2022 Q4	$144K	Hold	900	–	–	﹤0.01%	639
2022 Q3	$127K	Hold	900	–	–	﹤0.01%	677
2022 Q2	$132K	Hold	900	–	–	﹤0.01%	694
2022 Q1	$146K	Hold	900	–	–	﹤0.01%	712
2021 Q4	$170K	Buy	+900	New	+$174K	﹤0.01%	695

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

UMB Bank's BBH Position: Q1 2026 in Review

UMB Bank held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 900 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #741.

UMB Bank first reported a position in BBH in Q4 2021 and has held it in 18 quarters since. The position peaked at $170K in Q4 2025. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

UMB Bank held 900 shares of VanEck Biotech ETF worth $169K as of Q1 2026.
UMB Bank left its VanEck Biotech ETF share count unchanged in Q1 2026.
VanEck Biotech ETF made up ﹤0.01% of UMB Bank's portfolio in Q1 2026, its #741 holding.
UMB Bank first reported a position in VanEck Biotech ETF in Q4 2021 and has held it in 18 quarters since.
UMB Bank's VanEck Biotech ETF position peaked at $170K in Q4 2025.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.